Ukko uses an AI-driven computational protein design platform to develop immunotherapeutics for life-threatening food allergies. Using AI and protein micro-engineering, Ukko designs modified versions of allergens that do not trigger an allergic reaction but retrain the immune system to tolerate the allergen. The mission is to revolutionize allergy treatment and improve the lives of millions affected by food allergies.
AI named Ukko from July 2026 to September 2026.
Google AI ModeJul 23, 2026
Ukko: Uses AI to develop gluten and peanut proteins that are safe for people with allergies
None of these answers cited ukko.us. AI leaned on peakbridge.vc, aiforgood.itu.int, and amergingtech.nz.
ukko.us 0%Other sites 100%
Excerpts where Ukko appeared in the AI's answer
Ukko employs an AI-driven micro-engineering platform to redesign proteins at a molecular level.
Ukko: Uses AI to develop gluten and peanut proteins that are safe for people with allergies